Top Markets
#1 Songbird Songbird +15.68%
#2 TENDIES TENDIES +9.42%
#3 DAPPOS DAPPOS +9.36%
#4 pipedog pipedog +8.37%
#5 Prom Prom +7.95%
#6 Helium Helium +7.35%
#7 Collector Crypt Collector Crypt +6.69%
#8 MarsCoin MarsCoin +6.62%
#9 Cryptopia Cryptopia +5.90%
#10 Moolah Moolah +5.25%
Coin of the day
Songbird Songbird
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
MedPlus Health Services Limited MedPlus Health Services Limited

MedPlus Health Services Limited

MEDPLUS
Pozycja w akcjach #10055
MedPlus Health Services Limited operates primarily as an Indian retailer of... MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Cena akcji
$7.46
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$896.69M
Zmiana (1 dzień)
-1.74%
Zmiana (1 rok)
-21.84%
Kraj
IN
Handel MedPlus Health Services Limited (MEDPLUS)

Kategoria

Healthcare
Zyski dla MedPlus Health Services Limited (MEDPLUS)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych MedPlus Health Services Limited, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy MedPlus Health Services Limited od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT